{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:10:53Z","timestamp":1793988653784,"version":"4.8.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) encompasses a spectrum of inflammatory demyelinating disorders of the central nervous system (CNS). Recognized clinical phenotypes include optic neuritis (ON), transverse myelitis (TM), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis, aseptic meningitis, cortical encephalitis, demyelinating pseudotumor, and cranial nerve involvement. MOG antibody-associated cerebral cortical encephalitis (MOG-CCE) represents a rare but clinically significant subtype, often misdiagnosed due to heterogeneous clinical and neuroimaging features overlapping with other CNS disorders. We present a case of 36-year-old man with new-onset acute seizures and persistent headache. Initial brain magnetic resonance imaging (MRI) revealed no obvious signal abnormalities; however, subtle cortical swelling with sulcal effacement was identified in the left frontoparietal region, suggestive of focal cortical inflammation. Diagnostic workup revealed elevated MOG-IgG antibody titers in both serum and cerebrospinal fluid (CSF) using live cell-based assay. The patient demonstrated remarkable clinical response to combination immunotherapy with intravenous methylprednisolone and immunoglobulin. This case highlights the inclusion of MOG-CCE in the differential diagnosis of unexplained seizures and headaches accompanied by cortical swelling on neuroimaging, even in the absence of overt demyelinating lesions, and further underscores the critical role of early MOG-IgG testing and prompt immunotherapy to mitigate disease progression and improve neurological outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1619807","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:41:52Z","timestamp":1750225312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report highlighting diagnostic challenges and therapeutic implications"],"prefix":"10.3389","volume":"16","author":[{"given":"MengChan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaWei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000681","article-title":"Clinical spectrum of central nervous system myelin oligodendrocyte glycoprotein autoimmunity in adults","volume":"32","author":"Cobo-Calvo","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/antib13020043","article-title":"Myelin oligodendrocyte glycoprotein-antibody associated disease: an updated review of the clinical spectrum, pathogenetic mechanisms and therapeutic management","volume":"13","author":"Gklinos","year":"2024","journal-title":"Antib (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ana.26549","article-title":"Cerebral cortical encephalitis in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"93","author":"Valencia-Sanchez","year":"2023","journal-title":"Ann Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1203615","article-title":"Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000538","article-title":"Anti-MOG encephalitis mimicking small vessel CNS vasculitis","volume":"6","author":"Patterson","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome","volume":"266","author":"Budhram","year":"2019","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1720676","article-title":"Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders","volume":"130","author":"Tao","year":"2020","journal-title":"Int J Neurosci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.09.023","article-title":"Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies","volume":"18","author":"Zhou","year":"2017","journal-title":"Mult Scler Related Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.782490","article-title":"Myelin oligodendrocyte glycoprotein antibody associated cerebral cortical encephalitis: case reports and review of literature","volume":"15","author":"Shu","year":"2021","journal-title":"Front Hum Neurosci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","article-title":"The structure and function of myelin oligodendrocyte glycoprotein","volume":"72","author":"Johns","year":"1999","journal-title":"J Neurochem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1510097","article-title":"Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series","volume":"15","author":"Min","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/v8020051","article-title":"Infectious mononucleosis triggers generation of igG auto-Antibodies against native myelin oligodendrocyte glycoprotein","volume":"8","author":"Kakalacheva","year":"2016","journal-title":"Viruses"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241298065","article-title":"Epstein-Barr virus infection in patients with MOGAD","volume":"31","author":"Maniscalco","year":"2025","journal-title":"Mult Scler"},{"key":"B17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0165-5728(98)00254-9","article-title":"Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice","volume":"95","author":"Mokhtarian","year":"1999","journal-title":"J Neuroimmunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.12.035","article-title":"Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: A case report","volume":"28","author":"Aoe","year":"2019","journal-title":"Mult Scler Related Disord"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25291","article-title":"Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein","volume":"84","author":"Spadaro","year":"2018","journal-title":"Ann Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/children11070778","article-title":"FLAIR hyperintense cortical lesions in a 4-year-old child with myelin oligodendrocyte glycoprotein (MOG)-associated encephalitis and seizures: A case report","volume":"11","author":"Bernardi","year":"2024","journal-title":"Children (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"104881","DOI":"10.1016\/j.amsu.2022.104881","article-title":"A unilateral FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) case from a developing country: A case report","volume":"84","author":"Ahmed","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.722404","article-title":"Clinical and imaging features of patients with encephalitic symptoms and myelin oligodendrocyte glycoprotein antibodies","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ene.2019.26.issue-1","article-title":"Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China","volume":"26","author":"Wang","year":"2019","journal-title":"Eur J Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2022.09.016","article-title":"Clinical and MRI differential analysis of autoimmune encephalitis and viral encephalitis","volume":"18","author":"Tan","year":"2023","journal-title":"J Taibah Univ Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"122909","DOI":"10.1016\/j.jns.2024.122909","article-title":"Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"458","author":"Molazadeh","year":"2024","journal-title":"J Neurol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-019-0786-3","article-title":"Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination","volume":"7","author":"Tea","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1756286420945135","DOI":"10.1177\/1756286420945135","article-title":"Recent developments in MOG-IgG associated neurological disorders","volume":"13","author":"Hegen","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1038\/s41598-020-69182-w","article-title":"Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases","volume":"10","author":"Saxena","year":"2020","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain: J Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1619807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:41:53Z","timestamp":1750225313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1619807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2025.1619807"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1619807","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1619807"}}